Back

Discussion - Furosemide Withdrawal in Stable Chronic Outpatients with Heart Failure: a Double-blind, Multicenter, Randomized Trial

26 May 2019 (09:06 - 09:09)
Organised by:
Congress Presentation Part of: Late breaking trial II - Chronic heart failure Chronic Heart Failure HFA Premium Access Heart Failure 2019

12 More presentations in this session

Presentation thumbnail
Pharmacy-based interdisciplinary intervention for patients with chronic heart failure: results of the PHARM-CHF randomized controlled trial
Professor M. Schulz (Leipzig, DE)
Slides Video
Presentation thumbnail
Discussion - PHARM-CHF
Video
Presentation thumbnail
Patiromer to Enable Spironolactone in Patients with Resistant Hypertension and Chronic Kidney Disease (AMBER): Results in the Prespecified Subgroup with Heart Failure
Professor P. Rossignol (Monaco, MC)
Slides Video
Presentation thumbnail
Discussion - AMBER.
Video
Presentation thumbnail
Furosemide Withdrawal in Stable Chronic Outpatients with Heart Failure: a Double-blind, Multicenter, Randomized Trial
Doctor A. Biolo (Porto Alegre, BR)
Slides Video

Access the full session

Session thumbnail
Late breaking trial II - Chronic heart failure

The Event

Event poster

Heart Failure 2019

26 May 2019 09:06 CET
You may be interested in
thumbnail
Congress Presentation
Loop diuretic down titration at discharge in patients hospitalized for acute heart failure
20 May 2023
thumbnail
Webinar
How to implement new heart failure therapies in clinical practice
1 December 2022
thumbnail
Congress Presentation
Safety and tolerability of diuretics withdrawal in heart failure with reduced ejection fraction. The REDICAE trial
11 May 2024
thumbnail
Congress Session
Late-breaking clinical trials in chronic heart failure
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources